COVID-19: Consequences for Children With Cancer in Turkey and Globally

1. World Health Organization. Emergency: Coranavirus disease (COVID-19) pandemic. https ://ww w.who .int/ emerg encie s/dis eases /nove l-cor onavi rus-2 019.
2. Ministry of Health of Turkey. COVID-19 information platform. https ://co vid19 .sagl ik.go v.tr/ TR-66 935/g enel- koron aviru s-tab losu. html.
3. Saini KS, Tagliamento M, Lambertini M, et al. Mortality in patients with cancer and coronavirus disease 2019: A systematic review and pooled analysis of 52 studies. Eur J Cancer. 2020;139:43-50. [CrossRef]
4. Johns Hopkins University of Medicine: coronavirus resource center: mortality analyses. https://coronavirus.jhu.edu. Accessed February 9, 2021.
5. Kaltsas A, Sepkowitz K. Community acquired respiratory and gastrointestinal viral infections: challenges in the immunocompromised host. Curr Opin Infect Dis. 2012;25(4):423-430. [CrossRef]
6. Sullivan M, Bouffet E, Rodriguez-Galindo C, et al. The COVID-19 pandemic: A rapid global response for children with cancer from SIOP, COG, SIOP-E, SIOP-PODC, IPSO, PROS, CCI, and St Jude Global. Pediatr Blood Cancer. 2020 July;67(7):e28409. [CrossRef]
7. Bouffet E, Challinor J, Sullivan M, et al. Early advice on managing children with cancer during the COVID-19 pandemic and a call for sharing experiences. Pediatr Blood Cancer. 2020 July;67(7):e28327. [CrossRef]
8. Moreira DC, Sniderman E, Mukkada S, et al. The Global COVID-19 Observatory and Resource Center for Childhood Cancer: A response for the pediatric oncology community by SIOP and St. Jude Global. Pediatr Blood Cancer. 2021 May;68(5):e28962. [CrossRef].
9. Jude St. Global. Global registry of CovID-19 in Pediatric Cancer. https ://gl obal. stjud e.org /en-u s/glo bal-c ovid- 19-ob serva toryand- r esour ce-ce nter- for-c hildh ood-c ancer /regi stry. html. Accessed April 17,2021.
10. Kebudi R, Kurucu N, Tuğcu D, et al. COVID-19 infection in children with cancer and stem cell transplant recipients in Turkey: A nationwide study. Pediatr Blood Cancer. 2021;68(6):e28915. [CrossRef]
11. de Rojas T, Pérez-Martínez A, Cela E, et al. COVID-19 infection in children and adolescents with cancer in Madrid. Pediatr Blood Cancer. 2020;67(7):e28397. [CrossRef]
12. Boulad F, Kamboj M, Bouvier N, Mauguen A, Kung AL. COVID-19 in Children With Cancer in New York City. JAMA Oncol. 2020;6(9):1459-1460. [CrossRef]
13. Millen GC, Arnold R, Cazier JB, et al. Severity of COVID-19 in children: report from the United Kingdom Pediatric Coronavirus Cancer Monitoring Project. Br J Cancer. 2021;124(4):754-759. [CrossRef]
14. Hrusak O, Kalina T, Wolf J, et al. ‘Flash survey on severe acute respiratory syndrome coronavirus-2 infections in paediatric patients on anticancer treatment. Eur J Cancer. 2020;132:11-16. [CrossRef]
15. Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020;323(13):1239-1242. [CrossRef]
16. Turkish Ministry of Health. Current situation of COVID-19 in Turkey. https://covid19.saglik.gov.tr.2020.
17. Kutluk MT, Yesilipek A. Pediatric cancer registry Turkey: 2009-2016 (TPOG & TPHD). In: American Society of Clinical Oncology; J Clin Oncol. 2017;15(15_suppl):e22015.
18. Medetalibeyoğlu A, Şenkal N, Çapar G, Köse M, Tükek T. Characteristics of the initial patients hospitalized for COVID-19: a singlecenter report. Turk J Med Sci. 2020;50(5):1436-1439. [CrossRef]
19. Ferrari A, Zecca M, Rizzari C, et al. Children with cancer in the time of COVID-19: an 8 week report from the six pediatric onco-hematology centers in Lombardia, Italy. Pediatr Blood Cancer. 2020;67(8):e28410. [CrossRef]
20. DeBiasi RL, Song X, Delaney M, et al. Severe coronavirus Disease- 2019 in children and Young Adults in the Washington, DC, Metropolitan Region. J Pediatr. 2020;223:199-203.e1. [CrossRef]
21. Castagnoli R, Votto M, Licari A, et al. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in children and adolescents: a systematic review. JAMA Pediatr. 2020;174(9):882- 889. [CrossRef]
22. Bisogno G, Provenzi M, Zama D, et al. Clinical characteristics and outcome of severe acute respiratory syndrome coronavirus 2 infection in Italian pediatric oncology patients: A study from the Infectious Diseases Working Group of the Associazione Italiana di Oncologia e Ematologia Pediatrica. J Pediatric Infect Dis Soc. 2020;9(5):530-534. [CrossRef]
23. Fauro A, Rives S, Laseletta A, et al. Initial Reports on Spanish Pediatric Oncologic, Hematologic and, Post Stem Cell Transplantation Patients during SARS-COV-2 Pandemic Pediatr Bood Cancer 2020 Sep; 67(9):e28557. [CrossRef]
24. Shekerdemian LS, Mahmood NR, Wolfe KK, et al. Characteristics and outcomes of children with coronavirus disease 2019 (COVID- 19) infection admitted to US and Canadian pediatric intensive care units. JAMA Pediatr. 2020;174(9):868-873. [CrossRef]
25. Simpson S, Kay FU, Abbara S, et al. Radiological Society of North America expert consensus document on reporting chest CT findings related to COVID-19: endorsed by the Society of Thoracic Radiology, the American College of Radiology, and RSNA. Radiol Cardiothorac Imaging. 2020;2(2):e200152. [CrossRef]
26. Yasuhara J, Watanabe K, Takagi H, Sumitomo N, Kuno T. COVID-19 and multisystem inflammatory syndrome in children: a systematic review and meta-analysis. Pediatr Pulmonol. 2021 May;56(5):837- 848. [CrossRef]
27. Rostad CA, Chahroudi A, Mantus G, et al. Quantitative SARSCoV- 2 serology in children with multisystem inflammatory syndrome (MIS-C). Pediatrics. 2020;146(6):e2020018242. [CrossRef]
28. Belay ED, Abrams J, Oster ME, et al. Trends in geographic and temporal distribution of US children With multisystem inflammatory syndrome During the COVID-19 pandemic. JAMA Pediatr. 2021. [CrossRef]
29. National Institutes of Health. COVID-19 treatment guidelines: special considerations in children. https ://ww w.cov id19t reatm entgu ideli nes.n ih.go v/spe cial- popul ation s/chi ldren .
30. Sankar J, Dhochak N, Kabra SK, Lodha R. COVID-19 in children: clinical approach and management. Indian J Pediatr. 2020;87(6):433-442. [CrossRef]
31. Murphy ME, Clay G, Danziger-Isakov L, Schulert G, Paulsen GC. Acute severe respiratory syndrome coronavirus-2 treatment overwiev for pediatrics. Curr Opin Pediatr. 2021;33(1):129-135. [CrossRef]
32. Kebudi R, Kurucu N, Tuğcu D. Delays in treatment because of COVID-19 infection in children With cancer and stem-cell transplant recipients in Turkey. JCO Oncol Pract. 2021:OP2100047. [CrossRef]
33. Wu T.-Y.J, Kwon DH, Glover MJ, et al. Changes in Cancer Management due to COVID19 Illness in Patients with Cancer in Northern California. JCO Oncology Practice. 2021; 17(3): e377-e385. [CrossRef]
34.Vasquez L, Sampor C, Villanueva G, et al. Early impact of the COVID- 19 pandemic on paediatric cancer care in Latin America. Lancet Oncol. 2020;21(6):753-755. [CrossRef]
35. Saab R, Obeid A, Gachi F, et al. Impact of the coronavirus disease 2019 (COVID-19) pandemic on pediatric oncology care in the Middle East, North Africa, and West Asia region: A report from the Pediatric Oncology East and Mediterranean (POEM) group. Cancer. 2020 September 15;126(18):4235-4245. [CrossRef]
36. Graetz D, Agulnik A, Ranadive R, et al. Global effect of the COVID- 19 pandemic on paediatric cancer care: a cross-sectional study. Lancet Child Adolesc Health. 2021 March 3;5(5):332-340. [CrossRef]
37. Turkish Medical Assocation. First year evaluation report. https:// www.ttb.org.tr/kutuphane/1_yil_rapor.pdf. 2021.
38. Li Y, Scherer N, Felix L, Kuper H. Prevalence of depression, anxiety and post-traumatic stress disorder in health care workers during the COVID-19 pandemic: A systematic review and meta-analysis. PLOS ONE. 2021;16(3):e0246454. [CrossRef]
39. Tsagakis I, Papatriantafyllou M. Safeguarding cancer research funding by European charities amidst the COVID-19 pandemic. Mol Oncol. 2020;14(12):2987-2993. [CrossRef]
40.Burki TK. Cuts in cancer research funding due to COVID-19. Lancet Oncol. 2021;22(1):e6. [CrossRef]
41. Aygün D, Önal P, Apaydın G, Çokuğraş H. Coronavirus infections in childhood and vaccine studies. Turk Arch Pediatr. 2021; 56(1):10- 14. [CrossRef]

APA	Kebudi R, Chantada G, Kurucu N, Tugcu D, Mukkada S, Moreira D (2021). COVID-19: Consequences for Children With Cancer in Turkey and Globally. , 295 - 299. 10.5152/TurkArchPediatr.2021.21134
Chicago	Kebudi Rejin,Chantada Guillermo,Kurucu Nilgün,Tugcu Deniz,Mukkada Sheena,Moreira Daniel COVID-19: Consequences for Children With Cancer in Turkey and Globally. (2021): 295 - 299. 10.5152/TurkArchPediatr.2021.21134
MLA	Kebudi Rejin,Chantada Guillermo,Kurucu Nilgün,Tugcu Deniz,Mukkada Sheena,Moreira Daniel COVID-19: Consequences for Children With Cancer in Turkey and Globally. , 2021, ss.295 - 299. 10.5152/TurkArchPediatr.2021.21134
AMA	Kebudi R,Chantada G,Kurucu N,Tugcu D,Mukkada S,Moreira D COVID-19: Consequences for Children With Cancer in Turkey and Globally. . 2021; 295 - 299. 10.5152/TurkArchPediatr.2021.21134
Vancouver	Kebudi R,Chantada G,Kurucu N,Tugcu D,Mukkada S,Moreira D COVID-19: Consequences for Children With Cancer in Turkey and Globally. . 2021; 295 - 299. 10.5152/TurkArchPediatr.2021.21134
IEEE	Kebudi R,Chantada G,Kurucu N,Tugcu D,Mukkada S,Moreira D "COVID-19: Consequences for Children With Cancer in Turkey and Globally." , ss.295 - 299, 2021. 10.5152/TurkArchPediatr.2021.21134
ISNAD	Kebudi, Rejin vd. "COVID-19: Consequences for Children With Cancer in Turkey and Globally". (2021), 295-299. https://doi.org/10.5152/TurkArchPediatr.2021.21134

APA	Kebudi R, Chantada G, Kurucu N, Tugcu D, Mukkada S, Moreira D (2021). COVID-19: Consequences for Children With Cancer in Turkey and Globally. Turkish archives of pediatrics (Online), 56(4), 295 - 299. 10.5152/TurkArchPediatr.2021.21134
Chicago	Kebudi Rejin,Chantada Guillermo,Kurucu Nilgün,Tugcu Deniz,Mukkada Sheena,Moreira Daniel COVID-19: Consequences for Children With Cancer in Turkey and Globally. Turkish archives of pediatrics (Online) 56, no.4 (2021): 295 - 299. 10.5152/TurkArchPediatr.2021.21134
MLA	Kebudi Rejin,Chantada Guillermo,Kurucu Nilgün,Tugcu Deniz,Mukkada Sheena,Moreira Daniel COVID-19: Consequences for Children With Cancer in Turkey and Globally. Turkish archives of pediatrics (Online), vol.56, no.4, 2021, ss.295 - 299. 10.5152/TurkArchPediatr.2021.21134
AMA	Kebudi R,Chantada G,Kurucu N,Tugcu D,Mukkada S,Moreira D COVID-19: Consequences for Children With Cancer in Turkey and Globally. Turkish archives of pediatrics (Online). 2021; 56(4): 295 - 299. 10.5152/TurkArchPediatr.2021.21134
Vancouver	Kebudi R,Chantada G,Kurucu N,Tugcu D,Mukkada S,Moreira D COVID-19: Consequences for Children With Cancer in Turkey and Globally. Turkish archives of pediatrics (Online). 2021; 56(4): 295 - 299. 10.5152/TurkArchPediatr.2021.21134
IEEE	Kebudi R,Chantada G,Kurucu N,Tugcu D,Mukkada S,Moreira D "COVID-19: Consequences for Children With Cancer in Turkey and Globally." Turkish archives of pediatrics (Online), 56, ss.295 - 299, 2021. 10.5152/TurkArchPediatr.2021.21134
ISNAD	Kebudi, Rejin vd. "COVID-19: Consequences for Children With Cancer in Turkey and Globally". Turkish archives of pediatrics (Online) 56/4 (2021), 295-299. https://doi.org/10.5152/TurkArchPediatr.2021.21134